Literature DB >> 9491432

Alterations in membrane fluidity, lipid metabolism, mitochondrial activity, and lipophosphoglycan expression in pentamidine-resistant Leishmania.

M Basselin1, M Robert-Gero.   

Abstract

Cytoplasmic and mitochondrial membranes were studied in wild-type promastigotes of Leishmania donovani and L. amazonensis treated with pentamidine and in the parasites resistant to this drug. Analyses by flow cytometry showed membrane fluidification in resistant cells and a modification of the lipidic metabolism in pentamidine-treated cells and in resistant clones as compared with wild-type ones. Pentamidine decreased the amounts of membrane polar lipids, i.e., phospholipids, and neutral lipidic droplets in the cytoplasm. Perturbation of lipid constituents did not induce modifications of membrane acid phosphatase and protease activities. Lipophosphoglycan, the major cell-surface glycoconjugate, was no longer detected by Western blotting in resistant cells. The use of rhodamine 123 showed a decrease in transmembrane mitochondrial potential in wild-type cells treated with pentamidine and in resistant parasites. In conclusion, cytoplasmic and mitochondrial membranes and lipidic metabolism are altered in pentamidine-resistant parasites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491432     DOI: 10.1007/s004360050361

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  14 in total

1.  In vitro growth of Leishmania amazonensis promastigotes resistant to pentamidine is dependent on interactions among strains.

Authors:  P Agnew; P Holzmuller; Y Michalakis; D Sereno; J L Lemesre; F Renaud
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Authors:  Maya Berg; Raquel García-Hernández; Bart Cuypers; Manu Vanaerschot; José I Manzano; José A Poveda; José A Ferragut; Santiago Castanys; Jean-Claude Dujardin; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates.

Authors:  Johannes Austrup; Pantelis Ntais; Vasiliki Christodoulou; Jean-Pierre Dedet; Francine Pratlong; Maria Antoniou
Journal:  Parasitol Res       Date:  2014-02-07       Impact factor: 2.289

Review 4.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species.

Authors:  Daniel B Liarte; Silvane M F Murta
Journal:  Parasitol Res       Date:  2010-04-07       Impact factor: 2.289

6.  Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion.

Authors:  Mireille Basselin; Hubert Denise; Graham H Coombs; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  Correlation between glucose uptake and membrane potential in Leishmania parasites isolated from DCL patients with therapeutic failure: a proof of concept.

Authors:  Maritza Padrón-Nieves; Claudia Machuca; Emilia Díaz; Paulo Cotrim; Noris Rodriguez; Alicia Ponte-Sucre
Journal:  Parasitol Res       Date:  2014-03-27       Impact factor: 2.289

8.  Fatty acid profiles in Leishmania spp. isolates with natural resistance to nitric oxide and trivalent antimony.

Authors:  Alana Freire de Azevedo; Jorge Luís de Lisboa Dutra; Micheli Luize Barbosa Santos; Darlisson de Alexandria Santos; Péricles Barreto Alves; Tatiana Rodrigues de Moura; Roque Pacheco de Almeida; Marcelo Ferreira Fernandes; Ricardo Scher; Roberta Pereira Miranda Fernandes
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

9.  Metabolomics to unveil and understand phenotypic diversity between pathogen populations.

Authors:  Ruben t'Kindt; Richard A Scheltema; Andris Jankevics; Kirstyn Brunker; Suman Rijal; Jean-Claude Dujardin; Rainer Breitling; David G Watson; Graham H Coombs; Saskia Decuypere
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

Review 10.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.